Sodium 4-phenylbutyrate CAS NO.1716-12-7

Product Name:    Sodium 4-phenylbutyrate
Synonyms:    SPB;SODIUM 4-PHENYLBUTYRATE;SODIUM PHENYLBUTYRATE;PBNA;PHENYL N-BUTYRATE SODIUM SALT;4-PHENYLBUTYRATE, NA;4-PHENYLBUTYRIC ACID SODIUM;4-PHENYLBUTYRIC ACID SODIUM SALT
CAS:    1716-12-7
MF:    C10H11NaO2
MW:    186.18
EINECS:    605-612-7
Mol File:    1716-12-7.mol
                                         

storage temp.     room temp
solubility     H2O: ≥5mg/mL
form     White to slightly yellow solid
color     white to beige
InChIKey    OBKXEAXTFZPCHS-UHFFFAOYSA-N
CAS DataBase Reference    1716-12-7(CAS DataBase Reference)
Safety Information
Hazard Codes     Xi
Risk Statements     36
Safety Statements     26
WGK Germany     3
RTECS     CY9057220
HS Code     29163990
MSDS Information
Sodium 4-phenylbutyrate Usage And Synthesis
Description    Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, used in cancer and infection research.
Sodium phenylbutyrate stimulates urinary nitrogen excretion. It is a prodrug, which undergoes β-oxidation to phenylacetate. Sodium phenylbutyrate is used to treat urea cycle disorder. It might be associated with menstrual dysfunction, amenorrhea and painful mucositis of the esophagus and stomach.
Sodium phenylbutyrate has been used as an endoplasmic reticulum (ER) stress inhibitor to study the role of ER stress in the expression of betatrophin.
Chemical Properties    White or yellowish-white powder.
Uses    ACE inhibitor, antihypertensive, Inhibitor of histone deacetylase (HDAC). Anti-neoplastic agent and transcriptional regulator. Also acts as an inducer of tumor cytostasis and differentiation.
Sodium 4-phenylbutyrate is a chemical chaperone that has been shown to rescue the trafficking of misfolded proteins.It also weakly blocks histone deacetylase activity (IC50 = 0.4 mM), which results in cell cycle arrest, differentiation, and/or apoptosis of various tumors.Formulations containing sodium 4-phenylbutyrate have been used for the treatment of urea cycle disorders.
Definition    ChEBI: The organic sodium salt of 4-phenylbutyric acid. A prodrug for phenylacetate, it is used to treat urea cycle disorders.
Brand name    Buphenyl (Medicis).
Biological Activity    Sodium 4-Phenylbutyrate is a histone deacetylase inhibitor that displays anticancer activity. Inhibits cell proliferation, invasion and migration and induces apoptosis in glioma cells. Also inhibits protein isoprenylation, depletes plasma glutamine, increases production of fetal hemoglobin through transcriptional activation of the γ-globin gene and affects hPPARγ activation.